Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review

Valentina Lerose,Maria Ponticelli,Nadia Benedetto,Vittorio Carlucci,Ludovica Lela,Nikolay T. Tzvetkov,Luigi Milella
DOI: https://doi.org/10.3390/plants13060771
2024-03-09
Plants
Abstract:Withania somnifera (L.) Dunal is a medicinal plant belonging to the traditional Indian medical system, showing various therapeutic effects such as anti-cancer, anti-inflammatory, anti-microbial, anti-diabetic, and hepatoprotective activity. Of great interest is W. somnifera's potential beneficial effect against neurodegenerative diseases, since the authorized medicinal treatments can only delay disease progression and provide symptomatic relief and are not without side effects. A systematic search of PubMed and Scopus databases was performed to identify preclinical and clinical studies focusing on the applications of W. somnifera in preventing neurodegenerative diseases. Only English articles and those containing the keywords (Withania somnifera AND "neurodegenerative diseases", "neuroprotective effects", "Huntington", "Parkinson", "Alzheimer", "Amyotrophic Lateral Sclerosis", "neurological disorders") in the title or abstract were considered. Reviews, editorials, letters, meta-analyses, conference papers, short surveys, and book chapters were not considered. Selected articles were grouped by pathologies and summarized, considering the mechanism of action. The quality assessment and the risk of bias were performed using the Cochrane Handbook for Systematic Reviews of Interventions checklist. This review uses a systematic approach to summarize the results from 60 investigations to highlight the potential role of W. somnifera and its specialized metabolites in treating or preventing neurodegenerative diseases.
plant sciences
What problem does this paper attempt to address?
The main purpose of this paper is to systematically review and summarize the research progress on the traditional Indian medicinal plant Withania somnifera (L.) Dunal (Ashwagandha or Indian ginseng) in the prevention and treatment of neurodegenerative diseases. The authors focus on key diseases including Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington's disease. To achieve this goal, the researchers conducted a systematic literature search, screening relevant preclinical and clinical studies from the PubMed and Scopus databases. They specifically focused on studies that explored the effects of Ashwagandha and its active components on the aforementioned neurodegenerative diseases. Specifically, this review paper aims to: - Systematically evaluate published studies to summarize the neuroprotective effects of Ashwagandha and its unique metabolites (such as withanolides); - Screen and summarize the dosages used and the results obtained in different studies to provide references for future research directions; - Explore how Ashwagandha prevents neurotoxicity and the development of neurodegenerative conditions through mechanisms such as antioxidant pathways. In summary, this paper attempts to provide a comprehensive analysis of the potential roles and mechanisms of Ashwagandha in combating various neurodegenerative diseases through a systematic review, thereby offering theoretical basis and support for subsequent research.